Correction to: Diabetologia.
The incorrect figure legend was printed for Fig. 2. The correct legend should have read ‘Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD) or heart failure (HF)’, as per the figure heading.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at https://doi.org/10.1007/s00125-019-05039-w
Rights and permissions
About this article
Cite this article
Buse, J.B., Wexler, D.J., Tsapas, A. et al. Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD). Diabetologia 63, 1667 (2020). https://doi.org/10.1007/s00125-020-05151-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-020-05151-2